Next Article in Journal
Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis
Next Article in Special Issue
Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
Previous Article in Journal
Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview
Previous Article in Special Issue
The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(3), 674;

Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis

Rheumatology Division, Department of Internal Medicine, Hallym University Sacred Heart Hospital, 896, Pyongchondong, Dongan-gu, Anyang, Kyunggi-do 431-070, Korea
Department of Internal Medicine, Kangdong Sacred Heart Hospital, Seoul 05355, Korea
These authors contributed equally to work.
Author to whom correspondence should be addressed.
Received: 11 January 2018 / Revised: 14 February 2018 / Accepted: 21 February 2018 / Published: 27 February 2018
(This article belongs to the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis)
Full-Text   |   PDF [245 KB, uploaded 27 February 2018]   |  


Osteoarthritis (OA) is the most prevalent joint disease in older people and is characterized by the progressive destruction of articular cartilage, synovial inflammation, changes in subchondral bone and peri-articular muscle, and pain. Because our understanding of the aetiopathogenesis of OA remains incomplete, we haven’t discovered a cure for OA yet. This review appraises novel therapeutics based on recent progress in our understanding of the molecular pathogenesis of OA, including pro-inflammatory and pro-catabolic mediators and the relevant signalling mechanisms. The changes in subchondral bone and peri-articular muscle accompanying cartilage damage are also reviewed. View Full-Text
Keywords: osteoarthritis (OA); articular cartilage; molecular pathology; therapeutics osteoarthritis (OA); articular cartilage; molecular pathology; therapeutics

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Kim, J.-R.; Yoo, J.J.; Kim, H.A. Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis. Int. J. Mol. Sci. 2018, 19, 674.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top